Caspase-3 Regulatory Mechanisms

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 54: Line 54:
Hardy, J. A., J. Lam, et al. (2004). "Discovery of an allosteric site in the caspases." Proc Natl Acad Sci U S A 101(34): 12461-12466.
Hardy, J. A., J. Lam, et al. (2004). "Discovery of an allosteric site in the caspases." Proc Natl Acad Sci U S A 101(34): 12461-12466.
 +
 +
 +
==Testing==<StructureSection load='1H5I' size='500' side='right' caption='Caspase-3 (PDB entry [[1H5I]])' scene=''>Anything in this section will appear adjacent to the 3D structure and will be scrollable.</StructureSection>

Revision as of 20:24, 12 December 2012

Introduction

Caspases are cysteine-dependent aspartic acid proteases and are the key facilitators of apoptosis or programmed cell death. Apoptosis is tightly regulated by these caspases, and dysregulation of caspase functions have been implicated in wide variety of diseases such as neurodegeneration, cancer, heart disease and some metabolic disorders. As such, caspases are considered to be attractive drug targets to treat these disorders.

Existing as proenzymes, caspases undergo proteolytic processing at conserved aspartate residues in their intersubunit linker to produce the large and small subunit. These subunits then dimerize to form the active enzyme. Any apoptotic signal received by the cell results in sequential activation of caspases. Upstream or initator caspases (-2,-8, -9 and -10) are first activated by forming a holoenzyme wherein they associate with another protein platform or adaptor protein. Once active, initiator caspases cleave and activate the executioner caspases (-3, -6 and -7) which in turn cleave their respective protein targets initiating cell death.


Caspase-3 structure





Caspase-3 Active Site and Loop Bundle Analysis

Structure of Caspase-3 with substrate bound (PDB entry 2H5I)

Drag the structure with the mouse to rotate
Personal tools